The 3rd International Conference on Biopharmaceutics and Biologic Drugs, hosted by the Conferenceseries LLC was held during August 31-September 01, 2017 Philadelphia, USA based on the theme “Emerging Methods for the Characterization of Pharmaceutical and Biologic Products”. Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Biopharmaceutics, Biotech, Medical and pharmacy, who made this event a grand success.
In the United States , biologics are regulated by the FDA's Center for Biologics Evaluation and Research (CBER) whereas drugs are regulated by the Center for Drug Evaluation and Research . Approval may require several years of clinical trials , including trials with human volunteers. Even after the drug is released, it will still be monitored for performance and safety risks. The manufacture process must satisfy the FDA's "Good Manufacturing Practices", which are typically manufactured in a clean room environment with strict limits on the amount of airborne particles.